Global Diabetes Devices and Services Growth Opportunities

Global Diabetes Devices and Services Growth Opportunities

Growth Strategies in an Increasingly Competitive and Digitalized Environment

RELEASE DATE
06-Jan-2022
REGION
Global
Research Code: K6D9-01-00-00-00
SKU: HC03489-GL-MT_26161
$2,450.00
In stock
SKU
HC03489-GL-MT_26161
$2,450.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are definitely opportunities in disguise. These are in the form of business dynamics (including competitor advances), emerging disease management approaches, technology advances, and also Mega Trends driven by the pandemic. For each diabetes device manufacturer planning their short-term (1 to 3 year) and long-term (5 to 7 year) strategies, this study offers insights into what their peers within the same and adjacent device category are aiming for, how the pharmaceutical industry is impacting the diabetes space, the emerging disease management approaches and trends of virtual care, and how to target the huge emerging market potential, which remains unacknowledged and untapped. It also highlights the direction of the industry for each device type in the developed markets, allowing strategies to be aligned to market growth and avoiding competitive losses.

Author: Siddharth Shah

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on Diabetes Devices and Services

Growth Opportunities Fuel the Growth Pipeline Engine™

Segmentation

Growth Drivers

Growth Restraints

Overview of Opportunities and Threats

Trends and Threats for SMBG Participants

Trends and Threats for CGM Device Vendors

Trends and Threats for Insulin Pen Vendors

Trends and Threats for Insulin Pump Vendors

Summarized Insights

Summarized Insights (continued)

Select Trends of Focus

Pharma Participants Pushing Diabetes Management Solutions

New Business Models

Diabetes Start-up Acquisitions

Rising PE & VC Investment in Diabetes

Pivot to Diabetes Disease Management

Rise in Digital Diabetes ‘Reversal’ Management Solutions’ Adoption

Non-invasive Monitoring Tech and Wearables Emerging

Emerging Diabetes ‘Treatment’ Approaches

Global Diabetes Prevalence

Rise in Pre-diabetes and Diabetes Prevalence

Regional Distribution of Diabetics

Changes in Regional Share of Diabetics

Pre-diabetes—Another Cause for Concern

Target Regions for Diabetes & Pre-Diabetes Management

Care Models to Target Emerging Markets

India—Premium Offerings in a Large, Out-of-pocket Market

Africa’s Unique Needs Demand a Different Approach

Dubai’s Glucare—Integrated Care Model

Sector-wise Growth Strategies in Developed Markets

Sector-wise Growth Strategies in Developed Markets (continued)

Evolution of Approaches to Manage Chronic Condition Patients

Growth Opportunity 1—Active Disease Management Vendor Partnerships for Tapping Unaddressed Market Needs

Growth Opportunity 1—Active Disease Management Vendor Partnerships for Tapping Unaddressed Market Needs (continued)

Growth Opportunity 2—Enabling Digital Platforms for Diabetic’s Data Collection & Insights

Growth Opportunity 2—Enabling Digital Platforms for Diabetic’s Data Collection & Insights (continued)

Growth Opportunity 3—Developing Type 1 Diabetes-specific Disease Management Solutions with Insulin Pumps to Prepare for Competition

Growth Opportunity 3—Developing Type 1 Diabetes-specific Disease Management Solutions with Insulin Pumps to Prepare for Competition (continued)

Growth Opportunity 4—Targeting Wellness Applications for Non-Diabetics

Growth Opportunity 4—Targeting Wellness Applications for Non-Diabetics (continued)

Growth Opportunity 5—Tap Emerging Markets for Next Phase of Growth

Growth Opportunity 5—Tap Emerging Markets for Next Phase of Growth (continued)

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

Related Research
The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are definitely opportunities in disguise. These are in the form of business dynamics (including competitor advances), emerging disease management approaches, technology advances, and also Mega Trends driven by the pandemic. For each diabetes device manufacturer planning their short-term (1 to 3 year) and long-term (5 to 7 year) strategies, this study offers insights into what their peers within the same and adjacent device category are aiming for, how the pharmaceutical industry is impacting the diabetes space, the emerging disease management approaches and trends of virtual care, and how to target the huge emerging market potential, which remains unacknowledged and untapped. It also highlights the direction of the industry for each device type in the developed markets, allowing strategies to be aligned to market growth and avoiding competitive losses. Author: Siddharth Shah
More Information
No Index No
Podcast No
Author Siddharth Shah
Industries Healthcare
WIP Number K6D9-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A4B-B1